Kein Foto von Sven Stegemann

Scopus-Profil ansehen

Sven Stegemann

Univ.-Prof. Dr.phil.-nat.

20052023

Publikationen pro Jahr

Netzwerk

Amrit Paudel

Person

Carole Planchette

Person

Eva Faulhammer

Person

Johannes Khinast

Person

Diana A. van Riet-Nales

  • Medicines Evaluation Board
  • Chemical Pharmaceutical Assessments

Externe Person

Mario Maio

Externe Person

Mine Orlu

  • Université catholique de Louvain

Externe Person

J.-P. Baeyens

Externe Person

Andrew Barrett

  • Pfizer Inc.

Externe Person

Fatma Karapinar-Çarkit

  • OLVG Hospital, Department of Clinical Pharmacy
  • OLVG

Externe Person

Elisabeth Steinhagen-Thiessen

  • Charité – Universitätsmedizin Berlin

Externe Person

Peter Kraaks

Externe Person

Jan Span

  • Chemical Pharmaceutical Assessments

Externe Person

Patrick Hettrich

Externe Person

C. Azadi

  • Pfizer Inc.

Externe Person

Andriko Palmowski

  • Charité – Universitätsmedizin Berlin

Externe Person

Hugh D.C. Smyth

  • University of Texas at Austin

Externe Person

Catherine Tuleu

  • Université catholique de Louvain

Externe Person

D. R. Abernethy

  • U.S. Food and Drug Administration

Externe Person

Blanka Hirschlérova

  • State Institute for Drug Control

Externe Person

Regina Riedl

  • Medizinische Universität Graz
  • Max-Planck-Institut für Plasmaphysik

Externe Person

Li Ding

  • University of Texas at Austin

Externe Person

Arnoud W J Van't Hof

  • Maastricht University

Externe Person

Mariagiovanna Scarpa

  • Université catholique de Louvain

Externe Person

Rainer Wohlfahrt

Externe Person

Alpana Mair

  • Scottish Government

Externe Person

Jon S. B. de Vlieger

Externe Person

Felicity J. Smith

  • Université catholique de Louvain

Externe Person

A. Löfgren

Externe Person

Rogério Gaspar

Externe Person

Elizabeth Jamieson

  • Université catholique de Louvain

Externe Person

Marieke Voshaar

  • Universiteit Twente

Externe Person

Justin Kalafat

  • ACG North America, LLC

Externe Person

Elisavet Moutzouri

  • Universität Bern

Externe Person

Felix Ecker

Externe Person

Katarina Sundberg

  • Swedish Medical Products Agency (MPA)

Externe Person

Nicolas Rodondi

  • Universität Bern

Externe Person

Thilo Schmierer

Externe Person

Maarten de Wit

  • VU University Medical Center Amsterdam

Externe Person

Buttgereit Thomas

  • Charité – Universitätsmedizin Berlin

Externe Person

Doris Eggenschwyler

  • Swissmedic

Externe Person

Chris Moreton

  • FinnBrit Consulting

Externe Person

Rahel Eckardt-Felmberg

  • Charité – Universitätsmedizin Berlin

Externe Person

Johannes W Bijlsma

  • University Medical Center Utrecht

Externe Person

Graziano Onder

Externe Person

Ariane Schenk

  • Charité – Universitätsmedizin Berlin

Externe Person

Daniel Bar-Shalom

Externe Person

Fabrice Ruiz

  • ClinSearch

Externe Person

Margarete Shine

  • University College Cork

Externe Person

G. Schreier

Externe Person

Martin Opitz

Externe Person

Bahijja Raimi-Abraham

  • Université catholique de Louvain

Externe Person

Johannes G. Khinast

  • Research Center Pharmaceutical Engineering GmbH

Externe Person

Karin Schroten

  • Capsugel

Externe Person

Ashlee D. Brunaugh

  • University of Texas at Austin

Externe Person

Alessandra Rossi

  • Università Degli Studi di Parma

Externe Person

Hassan Benameur

Externe Person

Wayne Matthews

  • GlaxoSmithKline

Externe Person

Miles D. Witham

  • Newcastle University

Externe Person

Noah Forsat

  • Charité – Universitätsmedizin Berlin

Externe Person

Andreas Zimmer

  • Karl-Franzens-Universität Graz, Institut für Pharmazeutische Wissenschaften
  • Karl-Franzens-Universität Graz

Externe Person

Scott V. Jermain

  • University of Texas at Austin

Externe Person

Robert L. Ternik

  • Eli Lilly and Company

Externe Person

Bianca Broegmann

Externe Person

Karl Box

  • Pion Inc.

Externe Person

John Wahlich

  • Academy of Pharmaceutical Sciences

Externe Person

Bart van der Worp

  • University Medical Center Utrecht

Externe Person

Paul A.F. Jansen

  • Chemical Pharmaceutical Assessments
  • University Medical Center Utrecht
  • Expertise Centre Pharmacotherapy in Old Persons (EPHOR)

Externe Person

Huub Schellekens

Externe Person

Rodger Barnett

  • GlaxoSmithKline

Externe Person

Liz Sheehan

  • University College Cork

Externe Person

José da Silva

  • Centro Hospitalar e Universitário de Coimbra

Externe Person

T. Eissing

  • Bayer AG

Externe Person

David van Bodegom

  • Leyden Academy on Vitality and Ageing
  • Leiden University Medical Center - LUMC

Externe Person

Mansoor A. Khan

  • Texas A&M University

Externe Person

Francesca Cerreta

  • European Medicines Agency

Externe Person

F. Ecker

Externe Person

Simon Gaisford

  • Université catholique de Louvain

Externe Person

Abina M. Crean

  • University College Cork

Externe Person

E. Chanie

Externe Person

Macey Murray

  • Université catholique de Louvain

Externe Person

Simon Mooijaart

  • Leiden University Medical Center - LUMC

Externe Person

Anthonius de Boer

  • Chemical Pharmaceutical Assessments

Externe Person

Frank Buttgereit

  • Charité – Universitätsmedizin Berlin

Externe Person

Zakia Shariff

  • Aston University

Externe Person

M. Gogol

Externe Person

Paul Connolly

  • GlaxoSmithKline

Externe Person

Christel Schmelzer

Externe Person

A. Golden

  • University of Central Florida

Externe Person

Hanns-Christian Mahler

  • Lonza AG

Externe Person

Anne Marie Pense-Lheritier

  • Ecole de Biologie Industrielle

Externe Person

Beat Flühmann

Externe Person

Matthew J. Herpin

  • University of Texas at Austin

Externe Person

Li Wei

  • Université catholique de Louvain

Externe Person

R. Becker

Externe Person

E. Thesing-Bleck

Externe Person

J. F. Schlender

  • Universität Bonn

Externe Person

Sami Svanbäck

  • The Solubility Company Ltd

Externe Person

Katarzyna Stawarz

  • Université catholique de Louvain

Externe Person

Vinod P. Shah

Externe Person

Daan J. A. Crommelin

Externe Person

Bart van den Bemt

  • Sint Maartenskliniek
  • Radboud University Medical Center

Externe Person

F. Cerreta

Externe Person

Harald Sourij

  • Medizinische Universität Graz

Externe Person

Abigail Moran

  • Medicines and Healthcare products Regulatory Agency

Externe Person

Jörg Breitkreutz

  • Heinrich-Heine-Universität Düsseldorf
  • Heinrich Heine University Düsseldorf, Institut of Pharmaceutics and Biopharmaceutics

Externe Person

Patricia M Kearney

  • University College Cork

Externe Person

Fang Liu

  • University of Hertfordshire

Externe Person

Mike Aylott

  • GlaxoSmithKline

Externe Person

Laura Coll-Planas

  • Universitat Autònoma de Barcelona

Externe Person

Geneviève Motte

  • JEN Pharma Consulting

Externe Person

Brian Dooley

  • European Medicines Agency

Externe Person

Carsten Timpe

  • F. Hoffmann-La Roche Ltd.

Externe Person

Eva Roblegg

  • Research Center Pharmaceutical Engineering GmbH
  • Karl-Franzens-Universität Graz
  • BioTechMed-Graz
  • NAWI Graz Geozentrum
  • Research Centre for Pharmaceutical Engineering

Externe Person

Vera Weinstein

Externe Person

P. W. Slattum

  • Virginia Commonwealth University

Externe Person

Gilbert J. Burckart

Externe Person

Doninique Cadé

  • Capsugel

Externe Person

Satish K. Singh

  • Lonza AG

Externe Person

Stefan Mühlebach

Externe Person

Markus Koeller

  • Medizinische Universität Wien

Externe Person

Anthony Taylor

  • GlaxoSmithKline

Externe Person

S.W.J Lau

  • U.S. Food and Drug Administration

Externe Person

Maarten Boers

Externe Person

Siddharthya Mujumdar

  • F. Hoffmann-La Roche Ltd.

Externe Person

T. Shreeves

Externe Person

Antonio Jesus Quesada Navidad

  • CNIC - Spanish National Center for Cardiovascular Research

Externe Person